Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Megakaryocytes and Platelets, Harmful or Helpful in Breast Cancer Cell Metastasis

NCT06011824 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06011824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Megakaryocytes and Platelets, Harmful or Helpful in Breast Cancer Cell Metastasis
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
August 29, 2023
Completion date
April 29, 2025
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer